California 2025-2026 Regular Session

California Assembly Bill AB1037

Introduced
2/20/25  
Refer
3/10/25  
Report Pass
4/9/25  
Refer
3/10/25  
Report Pass
4/9/25  

Caption

Public health: substance use disorder.

Impact

This legislation is set to broaden the scope of public health initiatives by allowing individuals, including those who may assist in an overdose situation, to possess and distribute opioid antagonists without the requirement of formal training. By removing the training requirement, the bill aims to increase access to life-saving treatments during overdose situations, thus potentially reducing mortality rates associated with such incidents. Moreover, the bill eliminates certain restrictions related to drug paraphernalia, making it easier for individuals involved in harm reduction efforts to operate without fear of legal repercussions.

Summary

Assembly Bill 1037, introduced by Assembly Member Elhawary, focuses on public health measures addressing substance use disorders. The bill aims to amend existing laws regarding public access to hypodermic needles and syringes, extending the current authority for pharmacists and physicians to provide these items without a prescription indefinitely. Additionally, it mandates that pharmacists provide information regarding not only HIV and hepatitis C but also other bloodborne diseases, reinforcing preventive health measures for individuals at risk.

Sentiment

The overall sentiment surrounding AB 1037 appears to be supportive among public health advocates who view it as a significant step towards improving community health and safety. The emphasis on harm reduction practices is favored by those who argue that supportive measures can help mitigate the risks associated with drug use. However, there may be contention regarding the perceived leniency towards drug paraphernalia and the unfettered distribution of hypodermic supplies, which some critics might argue could enable substance use rather than discourage it.

Contention

One notable point of contention in the legislative discussions revolves around the changes to the definition of drug paraphernalia. Critics raise concerns about the implications of broadening exemptions for those engaged in harm reduction programs, fearing that it may inadvertently minimize accountability or the seriousness of substance use issues. Meanwhile, supporters advocate for these changes as necessary to address the public health crisis surrounding addiction and overdose, asserting that effective harm reduction strategies must be grounded in accessibility and community support.

Companion Bills

No companion bills found.

Similar Bills

VA HB2468

Advanced registered medication aides; administration of drugs.

CA AB423

Alcoholism or drug abuse recovery or treatment programs and facilities: disclosures.

CA SB43

Substance use disorder: addiction treatment referral agencies.

VA SB1257

Student & campus safety; opioid antagonist administration training for resident assistants required.

VA HB1637

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

VA SB1035

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

VA SB790

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

VA SB1363

Health Professions, Board of; transfer of powers and duties.